Table 1 Alcohol consumption and health-related traits of current drinkers in different response and longitudinal change groups.

From: Genome-wide analyses of behavioural traits are subject to bias by misreports and longitudinal changes

Intake level reported

Longitudinal change group

N

Mean phenotype

Disease prevalence (%)

AC

BMI

Disease count

CVD

T2D

DYSLIPID

HYPER

Yes

All

358,449

10.67 (0.02)

27.17 (0.01)

1.372 (0.002)

15.42 (0.06)

5.13 (0.04)

16.91 (0.06)

18.36 (0.06)

LESS

152,854 (42.6%)

8.56 (0.02)

27.77 (0.01)

1.506 (0.004)

17.80 (0.10)

7.20 (0.07)

19.17 (0.10)

21.12 (0.10)

SAME

134,808 (37.6%)

10.82 (0.03)

26.72 (0.01)

1.274 (0.004)

14.08 (0.09)

3.83 (0.05)

15.76 (0.10)

16.71 (0.10)

MORE

68,855 (19.2%)

15.11 (0.05)

26.68 (0.02)

1.266 (0.005)

12.77 (0.13)

3.10 (0.07)

14.12 (0.13)

15.40 (0.14)

No

All

66,058

28.28 (0.02)

1.630 (0.007)

17.70 (0.15)

8.16 (0.11)

18.07 (0.15)

21.27 (0.16)

LESS

38,799 (58.7%)

28.67 (0.03)

1.730 (0.009)

19.36 (0.20)

9.60 (0.15)

19.50 (0.20)

22.87 (0.21)

SAME

25,055 (37.9%)

27.70 (0.03)

1.474 (0.010)

15.26 (0.23)

6.09 (0.15)

15.93 (0.23)

18.93 (0.25)

MORE

1599 (2.4%)

27.43 (0.13)

1.448 (0.039)

13.82 (0.86)

4.88 (0.54)

14.70 (0.89)

16.20 (0.92)

  1. Shown are the descriptive characteristics of alcohol consumption and health-related traits. The numbers in the bracket in Mean phenotype and Disease prevalence columns are standard error of each mean/proportion estimate. LESS, SAME, and MORE denote the current drinkers who reduced, maintained, and increased their alcohol consumption, respectively, compared to 10 years ago. N, sample size; AC, alcohol consumption measured by units per week; BMI, body mass index (kg/m2); Disease count, number of common diseases affected; CVD: cardiovascular disease; T2D: type 2 diabetes; DYSLIPID: dyslipidaemia; and HYPER: hypertensive disease. A tiny proportion (<1%) of participants choose “Do not know” or “Prefer not to answer” are not listed in this Table but can be found in Supplementary Data 1c.